Skip to main content
SpringerLink
Log in

Survivin Expression in Medulloblastoma: A Possible Marker for Survival

  • Research
  • Published:
Pathology & Oncology Research

Abstract

Medulloblastomas are highly invasive tumors which are generally disseminated at the time of diagnosis. High and continued morbidity and mortality have prompted the search for new biologic markers that might be used for targeted therapy to minimise treatment related side effects. In this work, we studied the positive expression of survivin in medulloblastoma and investigated its relation to clinical, pathologic data and survival. Tumor tissue specimens from 47 patients with medulloblastoma who underwent primary surgical treatment from June 2002 to June 2006 at the Mansoura university hospital, Egypt were collected. Paraffin sections of all samples were submitted for immunohistochemistry using anti-survivin antibody. The relation between the percentage of positive survivin cells with clinical, pathological and survival data was evaluated Results: In 47 cancer tissue specimens, one case large-cell-anaplastic (1.12 %), tweleve cases desmoplastic (25.53 %) and 34 cases classic medulloblastomas (72.34 %). The immunohistochemical expression of survivin was nulear with moderate intensity. It does not correlate with either age or sex. There was a significant negative correlation of survivin expression with survival (p < 0.001), where negative survivin immunostaining was associated with prolonged overall and disease free survival, while survivin expression was associated with shortened survival. Conclusion: Survivin expression correlate with the clinical outcome with poor prognosis and could be a potential predictive factor for recurrence or metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Bowers DC, Gargan L, Weprin BE, Muline AF, Elterman RD, Munoz L, Giller CA, Winick NJ (2007) Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma. J Neurosurg 107(1 Suppl Pediatrics):5–10

    PubMed  Google Scholar 

  2. Rossi A, Caracciolo V, Russo G, Reiss K, Giordano A (2008) Medulloblastoma: from molecular pathology to therapy review. Clin Cancer Res 14(4):971–976

    Article  PubMed  CAS  Google Scholar 

  3. Sasaki T, Lopes MBS, Hankins GR, Helm GA (2002) Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system. Acta Neuropathol 104:105–109

    Article  PubMed  CAS  Google Scholar 

  4. Li XN, Shu Q, Su JM, Adesina AM, Wong KK, Perlaky L, Antalffy BA, Blaney SM, Lau CC (2007) Differential expression of survivin splice isoforms in medulloblastomas. Neuropathol Appl Neurobiol 33:67–76

    Article  PubMed  Google Scholar 

  5. Liu R, Mitchell DA (2010) Survivin as an immunotherapeutic target for adult and pediatric malignant brain tumors. Cancer Immunol Immunother 59:183–193

    Article  PubMed  Google Scholar 

  6. Fangusaro JR, Jiang Y, Holloway MP, Caldas H, Singh V, Boue DR, Hayes J, Altura RA (2005) Survivin, Survivin-2B, and Survivin-deltaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome. British J Cancer 92:359–365

    CAS  Google Scholar 

  7. Chang CH, Housepian EM, Herbert C Jr (1969) An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 93:1351–1359

    PubMed  CAS  Google Scholar 

  8. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (Eds.) (2007) WHO Classification of tumours of the central nervous system. IARC: Lyon 8:132–140

  9. Packer RJ, Vezina G (2008) Management of and Prognosis with Medulloblastoma. Ther Crossroads Arch Neurol 65(11):1419–1424

    Article  Google Scholar 

  10. Packer RJ, Cogen P, Vezina G, Rorke LB (1999) Medulloblastoma: clinical and biologic aspects. Neuro-Oncology 1:232–250

    PubMed  CAS  Google Scholar 

  11. Gilbertson RJ (2004) Medulloblastoma: signalling a change in treatment. Lancet Oncol 5:209–18

    Article  PubMed  Google Scholar 

  12. Roberts RO, Lynch CF, Jones MP, Hart MN (1991) Medulloblastoma: a population-based study of 532 cases. J Neuropathol Exp Neurol 50:134–144

    Article  PubMed  CAS  Google Scholar 

  13. Giordana MT, Schiffer P, Lanotte M, Girardi P, Chio A (1999) Epidemiology of adult medulloblastoma. Int J Cancer 80:689–692

    Article  PubMed  CAS  Google Scholar 

  14. Koeller KK, Rushing EJ (2003) From the archives of the AFIP Medulloblastoma: a comprehensive review with radiologic-pathologic correlation. AFIP ARCHIVES 23:1613–1637

    Google Scholar 

  15. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC (1998) Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580–584

    Article  PubMed  CAS  Google Scholar 

  16. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3(8):917–921

    Article  PubMed  CAS  Google Scholar 

  17. Deveraux QL, Reed JC (1999) IAP family proteins—suppressors of apoptosis. Genes Dev 13:239–252

    Article  PubMed  CAS  Google Scholar 

  18. Pizem J, Cört A, Zadravec-Zaletel L, Popovic M (2005) Survivin is a negative prognostic marker in medulloblastoma. Neuropathol Appl Neurobiol 31(4):422–8

    Article  PubMed  CAS  Google Scholar 

  19. Faccion RS, Ferreira RM, Grabois MF, Fonseca TC, de Oliveira JA, Maia RC (2011) Lack of prognostic significance of survivin in pediatric medulloblastoma. Pathol Oncol Res 17(4):899–908

    Article  PubMed  CAS  Google Scholar 

  20. Haberler C, Slavc I, Czech T, Gelpi E, Heinzl H, Budka H, Urban C, Scarpatetti M, Ebetsberger-Dachs G, Schindler C, Jones N, Klein-Franke A, Maier H, Jauk B, Kiefer A, Hainfellner JA (2006) Histopathological prognostic factors in medulloblastoma: high expression of survivin is related to unfavourable outcome. Eur J Cancer 42(17):2996–3003

    Article  PubMed  CAS  Google Scholar 

  21. Duo-bin W, Yong-ming J, Ming-xue NU, et al. (2009–01) Survivin Expression in Medulloblastoma and its Clinical Significance West China Medical Journal

  22. Bodey B, Bodey V, Siegel SE, Kaiser HE (2004) Survivin expression in childhood medulloblastomas: a possible diagnostic and prognostic marker. In vivo 18:713–718

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt

    Azza Abdel-Aziz & Mie Ali Ali Mohamed

  2. Clinical Oncology and Nuclear Medicine Department, Faculty of medicine, Mansoura University Hospital, Mansoura, Egypt

    Fatma Mohamed Farouk Akl

  3. Neurosurgery department, Faculty of Medicine, Mansoura University, Mansoura, Egypt

    Ahmed Nageeb M. Taha

Authors
  1. Azza Abdel-Aziz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mie Ali Ali Mohamed
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fatma Mohamed Farouk Akl
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ahmed Nageeb M. Taha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fatma Mohamed Farouk Akl.

Additional information

Condesed abstract

Survivin is a negative prognostic marker in medulloblastoma.

All authors have read and approved the manuscript and this manuscript is not under consideration elsewhere.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abdel-Aziz, A., Mohamed, M.A.A., Akl, F.M.F. et al. Survivin Expression in Medulloblastoma: A Possible Marker for Survival. Pathol. Oncol. Res. 19, 413–419 (2013). https://doi.org/10.1007/s12253-012-9594-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-012-9594-9

Keywords

Search

Navigation